Mylan Laboratories, Inc. (NASDAQ:MYL)

CAPS Rating: 4 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Recs

0
Player Avatar ruinas (< 20) Submitted: 11/16/2010 3:34:56 PM : Outperform Start Price: $18.96 MYL Score: +2.01

Improved sales of generics with economic doubt in US now.

Featured Broker Partners


Advertisement